BC
DGX icon

Bridgefront Capital’s Quest Diagnostics DGX Stock Holding History

Bridgefront Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$730K Buy
+3,445
New +$676K 0.19% 179
2025
Q2 		– Sell
-6,456
Closed -$1.09M – 658
2025
Q1 		$1.09M Buy
+6,456
New +$1.06M 0.32% 69
2024
Q4 		– Sell
-2,063
Closed -$320K – 628
2024
Q3 		$320K Sell
2,063
-1,645
-44% -$246K 0.12% 297
2024
Q2 		$508K Buy
+3,708
New +$508K 0.21% 161
2023
Q4 		– Sell
-5,689
Closed -$693K – 417
2023
Q3 		$693K Buy
+5,689
New +$758K 0.49% 32
2022
Q3 		– Sell
-4,395
Closed -$584K – 345
2022
Q2 		$584K Buy
+4,395
New +$599K 0.65% 21
2021
Q1 		– Sell
-3,878
Closed -$462K – 731
2020
Q4 		$462K Buy
+3,878
New +$473K 0.16% 235

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Bridgefront Capital's DGX Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Quest Diagnostics (DGX) in Q2 2026: 3,445 shares worth $730K. The stake represents 0.19% of the portfolio and ranks #179 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in DGX as recently as Q1 2025.

Bridgefront Capital first reported a position in DGX in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.09M in Q1 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Bridgefront Capital held 3,445 shares of Quest Diagnostics worth $730K as of Q2 2026.
  • Quest Diagnostics was a new Bridgefront Capital position in Q2 2026.
  • Quest Diagnostics made up 0.19% of Bridgefront Capital's portfolio in Q2 2026, its #179 holding.
  • Bridgefront Capital first reported a position in Quest Diagnostics in Q4 2020 and has held it in 7 quarters since.
  • Bridgefront Capital's Quest Diagnostics position peaked at $1.09M in Q1 2025.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.